Hanall Biopharma Revenue

Hanall Biopharma had revenue of 40.80B KRW in the quarter ending September 30, 2025, with 10.76% growth. This brings the company's revenue in the last twelve months to 154.05B, up 14.76% year-over-year. In the year 2024, Hanall Biopharma had annual revenue of 138.94B with 2.99% growth.

Revenue (ttm)

154.05B

Revenue Growth

+14.76%

P/S Ratio

17.21

Revenue / Employee

506.75M

Employees

304

Market Cap

2,650.71B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	138.94B	4.03B	2.99%
Dec 31, 2023	134.91B	24.91B	22.65%
Dec 31, 2022	110.00B	8.40B	8.27%
Dec 31, 2021	101.59B	12.99B	14.66%
Dec 31, 2020	88.60B	-19.85B	-18.30%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Celltrion Pharm	274.73B
Daewoong Pharmaceutical	1,541.65B
GC Biopharma	1,934.38B
Hanmi Pharm.	1,466.18B
Chong Kun Dang Pharmaceutical	1,680.99B
Yuhan	2,136.67B
Ildong Pharmaceutical	575.66B
Daewoong	2,055.93B

Revenue Rankings